Microbot Medical, Inc. June 03, 2024 - by Joey Ramson $MBOT is up over 100% and leading the Prism MarketView MedDevices index after they received FDA approval for a clinical trial for its LIBERTY® Endovascular Robotic Surgical System Share this article:
